BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 3322865)

  • 21. [Ambroxol in the treatment of idiopathic respiratory distress syndrome].
    Durisová A
    Cesk Pediatr; 1992 Jul; 47(7):421-3. PubMed ID: 1394543
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [A controlled study on the action of a new formulation of ambroxol in asthmatiform bronchitis in children].
    Baldini G; Gucci M; Tarò D; Memmini C
    Minerva Pediatr; 1989 Feb; 41(2):91-5. PubMed ID: 2661989
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Ambroxol versus betamethasone for stimulating antepartal lung maturity--a multicenter study].
    Salzer H; Weidinger H; Simbruner G; Vytiska-Binstorfer E
    Z Geburtshilfe Perinatol; 1986; 190(1):49-59. PubMed ID: 3515786
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Results of a clinical trial with ambroxol as to postoperative therapy of bronchitis (author's transl)].
    Kranicke R
    Arzneimittelforschung; 1978; 28(5a):934-5. PubMed ID: 581994
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Long-term treatment of chronic bronchitis with ambroxol].
    Schöpp W
    ZFA (Stuttgart); 1981 Sep; 57(26):1778-86. PubMed ID: 7303838
    [No Abstract]   [Full Text] [Related]  

  • 26. [Clinical experience with ambroxol syrup (author's transl)].
    Göbel P; Rensch H
    Arzneimittelforschung; 1978; 28(5a):929-31. PubMed ID: 581992
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Ambroxol].
    Akkoca Yildiz O
    Tuberk Toraks; 2006; 54 Suppl 1():3-14. PubMed ID: 17089236
    [No Abstract]   [Full Text] [Related]  

  • 28. [Efficacy of intravenous or atomizing ambroxol for prevention of respiratory distress syndrome in preterm infants].
    Hu Q; Lian JM; Li JQ
    Zhongguo Dang Dai Er Ke Za Zhi; 2006 Aug; 8(4):301-3. PubMed ID: 16923362
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ambroxol and simple chronic bronchitis. Effects on subjective symptoms and ventilatory function.
    Ericsson CH; Juhasz J; Jönsson E; Mossberg B
    Respiration; 1987; 51 Suppl 1():33-6. PubMed ID: 3299565
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The antenatal use of ambroxol (bromhexine metabolite VIII) to prevent hyaline membrane disease: a controlled double-blind study.
    Wauer RR; Schmalisch G; Menzel K; Schröder M; Müller K; Tiller R; Methfessel G; Sitka U; Koepke E; Plath C; Schlegel C; Böttcher M; Köppe I; Fricke U; Severin K; Jacobi R; Schmidt W; Hinkel GK; Nitz I; Kunze D; Reichmann G; Lachmann B; Lampe K; Grauel EL
    Int J Biol Res Pregnancy; 1982; 3(2):84-91. PubMed ID: 7042592
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A controlled trial of ambroxol in chronic bronchitis.
    Guyatt GH; Townsend M; Kazim F; Newhouse MT
    Chest; 1987 Oct; 92(4):618-20. PubMed ID: 3308343
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Prophylaxis and treatment of bronchopulmonary complications with ambroxol administered by infusion in elderly patients undergoing surgery].
    Bavaro P; Biscari P
    G Chir; 1989 Oct; 10(10):605-9. PubMed ID: 2518303
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Possibility of interaction among antibiotics and mucolytics in children.
    Principi N; Zavattini G; Daniotti S
    Int J Clin Pharmacol Res; 1986; 6(5):369-72. PubMed ID: 3781700
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Therapeutic activity of ambroxol theophyllinacetate in chronic obstructive pulmonary diseases.
    Primbs K
    Clin Ther; 1985; 7(6):733-6. PubMed ID: 4075364
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Effectiveness of lasolvan and bromhexine in chronic nonspecific lung diseases].
    Solopov VN; Lunichkina IV; Plisko LF
    Sov Med; 1989; (6):82-4. PubMed ID: 2678522
    [No Abstract]   [Full Text] [Related]  

  • 36. Ambroxol for the prevention of chronic bronchitis exacerbations: long-term multicenter trial. Protective effect of ambroxol against winter semester exacerbations: a double-blind study versus placebo.
    Olivieri D; Zavattini G; Tomasini G; Daniotti S; Bonsignore G; Ferrara G; Carnimeo N; Chianese R; Catena E; Marcatili S
    Respiration; 1987; 51 Suppl 1():42-51. PubMed ID: 3299567
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Incorporation of a stimulant of the synthesis and secretion of pulmonary surfactant (ambroxol) in the medical treatment of serous otitis].
    Calero del Castillo JB; Pérez Martínez F; Piqueras Pérez F; Redondo Luciáñez ER
    An Otorrinolaringol Ibero Am; 1988; 15(2):209-18. PubMed ID: 3389499
    [No Abstract]   [Full Text] [Related]  

  • 38. [New concepts in the therapy of mucostasis].
    von Seefeld H; Weiss JM; Rensch H
    Prax Klin Pneumol; 1983 Oct; 37 Suppl 1():896-900. PubMed ID: 6689074
    [No Abstract]   [Full Text] [Related]  

  • 39. [Effect of lasolvan on the rheologic properties of sputum].
    Chuchalin AG; Solopov VN; Kolganova NA; Plisko LF
    Klin Med (Mosk); 1987 Mar; 65(3):52-4. PubMed ID: 3298838
    [No Abstract]   [Full Text] [Related]  

  • 40. [Oxidative and anti-oxidative effects of ambroxol on acute hydrochloric acid-induced lung injury in rats].
    Zhao SP; Guo QL; Wang RK; Wang E
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2004 Oct; 29(5):586-8. PubMed ID: 16137054
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.